fenofibrate has been researched along with Arterial Diseases, Carotid in 3 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "The combination of antihypertensive agents with micronized fenofibrate can effectively prevent the progression of carotid atherosclerosis and reduce the incidence of stroke in patients with essential hypertension." | 9.12 | Inhibitory effects of micronized fenofibrate on carotid atherosclerosis in patients with essential hypertension. ( Meng, QH; Su, G; Zhu, S, 2006) |
| "The aim of this substudy was to ascertain whether long-term treatment with fenofibrate reduces surrogate measures of atherosclerosis, biomarkers of inflammation, and endothelial activation in patients with type 2 diabetes." | 5.13 | Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus. ( Hiukka, A; Hulten, LM; Keech, AC; Leinonen, ES; Salonen, JT; Taskinen, MR; Tuomainen, TP; Watanabe, H; Westerbacka, J; Wiklund, O; Yki-Järvinen, H, 2008) |
| "The combination of antihypertensive agents with micronized fenofibrate can effectively prevent the progression of carotid atherosclerosis and reduce the incidence of stroke in patients with essential hypertension." | 5.12 | Inhibitory effects of micronized fenofibrate on carotid atherosclerosis in patients with essential hypertension. ( Meng, QH; Su, G; Zhu, S, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hiukka, A | 1 |
| Westerbacka, J | 1 |
| Leinonen, ES | 1 |
| Watanabe, H | 1 |
| Wiklund, O | 1 |
| Hulten, LM | 1 |
| Salonen, JT | 1 |
| Tuomainen, TP | 1 |
| Yki-Järvinen, H | 1 |
| Keech, AC | 1 |
| Taskinen, MR | 1 |
| Zhu, S | 1 |
| Su, G | 1 |
| Meng, QH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Single Oral Tolvaptan Tablets on Hemodynamic Parameters in Subjects With Heart Failure[NCT00132886] | Phase 2 | 140 participants (Anticipated) | Interventional | 2004-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 trials available for fenofibrate and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Long-term effects of fenofibrate on carotid intima-media thickness and augmentation index in subjects with type 2 diabetes mellitus.
Topics: Acute-Phase Proteins; Aged; Biomarkers; C-Reactive Protein; Carotid Arteries; Carotid Artery Disease | 2008 |
Inhibitory effects of micronized fenofibrate on carotid atherosclerosis in patients with essential hypertension.
Topics: Anti-Inflammatory Agents; Antihypertensive Agents; Biomarkers; Carotid Artery Diseases; Demography; | 2006 |
1 other study available for fenofibrate and Arterial Diseases, Carotid
| Article | Year |
|---|---|
Niacin, fenofibrates increase benefits for statin users. These HDL- raising, triglyceride-lowering drugs beat out the use of additional LDL-lowering drugs.
Topics: Carotid Artery Diseases; Cholesterol, HDL; Female; Fenofibrate; Humans; Hyperlipidemias; Hypolipidem | 2010 |